Clinical Trial Update: Safety and Efficacy Study of AMG 073 in Hemodialysis Subjects [Phase 3]

View source ↗

Summary

Amgen's AMG 073 completed a Phase 3 trial evaluating safety and efficacy in adults with hyperparathyroidism undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• AMG 073

Snippet

Sponsor: Amgen | Conditions: Hyperparathyroidism | Phase 3 | Status: COMPLETED